Lifecome Biochemistry Co Ltd Net Asset Quality Index
Lifecome Biochemistry Co Ltd net asset quality index. Lifecome Biochemistry Co Ltd (002868) has a Net Asset Quality Index of 9.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥729.16 Million minus total liabilities of CN¥656.81 Million yields net assets of CN¥72.35 Million. A higher index indicates a stronger, lower-leverage balance sheet. See 002868 net asset value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Lifecome Biochemistry Co Ltd (2012–2025)
Net asset quality index of Lifecome Biochemistry Co Ltd from 2012 to 2025. This chart shows how Lifecome Biochemistry Co Ltd's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the index stands at 9.9%, representing net assets of CN¥72.35 Million against total assets of CN¥729.16 Million CNY. Check 002868 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Lifecome Biochemistry Co Ltd Net Asset Quality Index by Year (2012–2025)
Lifecome Biochemistry Co Ltd net asset quality index by year from 2012 to 2025. The table below presents the year-by-year Net Asset Quality Index for Lifecome Biochemistry Co Ltd from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Lifecome Biochemistry Co Ltd stock valuation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 8.7% | CN¥64.93 Million | CN¥748.71 Million | CN¥683.78 Million | ▲ +10.3 pp |
| 2024 | -1.6% | CN¥-24.54 Million | CN¥1.49 Billion | CN¥1.52 Billion | ▼ -22.7 pp |
| 2023 | 21.1% | CN¥414.11 Million | CN¥1.97 Billion | CN¥1.55 Billion | ▼ -27.3 pp |
| 2022 | 48.3% | CN¥599.30 Million | CN¥1.24 Billion | CN¥640.56 Million | ▼ -9.0 pp |
| 2021 | 57.4% | CN¥722.02 Million | CN¥1.26 Billion | CN¥536.38 Million | ▼ -21.8 pp |
| 2020 | 79.2% | CN¥769.94 Million | CN¥972.50 Million | CN¥202.56 Million | ▲ +2.1 pp |
| 2019 | 77.1% | CN¥778.50 Million | CN¥1.01 Billion | CN¥231.55 Million | ▼ -15.2 pp |
| 2018 | 92.3% | CN¥740.37 Million | CN¥802.42 Million | CN¥62.05 Million | ▲ +0.3 pp |
| 2017 | 92.0% | CN¥695.68 Million | CN¥756.25 Million | CN¥60.56 Million | ▲ +18.8 pp |
| 2016 | 73.2% | CN¥271.34 Million | CN¥370.66 Million | CN¥99.32 Million | ▲ +12.3 pp |
| 2015 | 60.9% | CN¥238.98 Million | CN¥392.52 Million | CN¥153.54 Million | ▲ +12.0 pp |
| 2014 | 48.9% | CN¥190.87 Million | CN¥390.09 Million | CN¥199.22 Million | ▲ +6.1 pp |
| 2013 | 42.8% | CN¥169.42 Million | CN¥395.88 Million | CN¥226.45 Million | ▲ +0.7 pp |
| 2012 | 42.1% | CN¥156.45 Million | CN¥371.37 Million | CN¥214.92 Million | — |